TrialX provides cutting-edge information on new medical treatments and clinical trials in your area.
Meet Dory , your personalized virtual assistant to find clinical trials. Go head, ask her anything. x
All > Massachusetts Investigators

Matthew H. Kulke

Dana-Farber/Harvard Cancer Center at Dana ...


Boston, Massachusetts - 02115 (617-632-4001)

Dana-Farber Cancer Institute


Boston, Massachusetts - 02115
  • CLINICAL TRIALS 3
  • CONDITIONS5
  • INTERVENTIONS6
  • SINCE2007
Octreotide and Interferon Alfa-2b or Bevacizumab in Treating Patients With Metastatic or Locally Advanced High-Risk Neuroendocrine Tumor

December 2007 - January 2012
AMG 479 in Advanced Carcinoid and Pancreatic Neuroendocrine Tumors

March 2010 - November 2011
Safety and Efficacy of Pasireotide Long Acting Release vs. Octreotide Long Acting Release in Patients With Metastatic Carcinoid Disease

April 2008 - August 2011
Carcinoma

Neuroendocrine Tumors

Carcinoid Tumor

Adenoma, Islet Cell

Carcinoma, Neuroendocrine

Bevacizumab

Recombinant Interferon Alfa-2b

Octreotide Acetate

Amg 479

Octreotide

Pasireotide

©2013 Applied Informatics, Inc.
As Seen On:
  • New York Times
  • USA Today
  • bio-itworld logo